Cost-effectiveness of different surgical treatment approaches for early breast cancer: a retrospective matched cohort study from China

Abstract Background Both breast-conserving surgery and breast reconstruction surgery are less popular in China, although they can improve patients’ quality of life. The main reason comes from the economy. There is currently no economic evaluation of different surgical treatment options for early bre...

Full description

Bibliographic Details
Main Authors: Qing Yang, Xiaorong Zhong, Wei Zhang, Ting Luo, Ping He, Hong Zheng
Format: Article
Language:English
Published: BMC 2021-02-01
Series:BMC Cancer
Subjects:
Online Access:https://doi.org/10.1186/s12885-021-07840-6
_version_ 1818459710105321472
author Qing Yang
Xiaorong Zhong
Wei Zhang
Ting Luo
Ping He
Hong Zheng
author_facet Qing Yang
Xiaorong Zhong
Wei Zhang
Ting Luo
Ping He
Hong Zheng
author_sort Qing Yang
collection DOAJ
description Abstract Background Both breast-conserving surgery and breast reconstruction surgery are less popular in China, although they can improve patients’ quality of life. The main reason comes from the economy. There is currently no economic evaluation of different surgical treatment options for early breast cancer. Our study aims to assess the economic impact and long-term cost-effectiveness of different surgical treatments for early breast cancer. The surgical approaches are including mastectomy (MAST), breast-conserving therapy (BCT), and mastectomy with reconstruction (MAST+RECON). Methods Based on demographic data, disease-related information and other treatments, we applied propensity score matching (PSM) to perform 1: 1 matching among patients who underwent these three types of surgery in the tertiary academic medical center from 2011 to 2017 to obtain a balanced sample of covariates between groups. A Markov model was established. Clinical data and cost data were obtained from the medical records. Health utility values were derived from clinical investigations. Strategies were compared using an incremental cost-effectiveness ratio (ICER). Results After PSM, there were 205 cases in each group. In the matched data set, the distribution of covariates was fully balanced. The total cost of MAST, MAST+RECON and BCT was $37,392.84, $70,556.03 and $82,330.97, respectively. The quality-adjusted life year (QALYs) were 17.11, 18.40 and 20.20, respectively. Compared with MAST, MAST+RECON and BCT have an ICER of $25,707.90/QALY and $14,543.08/QALY, respectively. The ICER of BCT vs. MAST was less than the threshold of $27,931.04. The reliability and stability of the results were confirmed by Monte Carlo simulation and sensitivity analysis. Conclusions We believe that in the context of the limited resources in China, after comparing the three surgical approaches, BCT is the more cost-effective and preferred solution.
first_indexed 2024-12-14T23:18:40Z
format Article
id doaj.art-b186f151d74a431493fce6c042968d1b
institution Directory Open Access Journal
issn 1471-2407
language English
last_indexed 2024-12-14T23:18:40Z
publishDate 2021-02-01
publisher BMC
record_format Article
series BMC Cancer
spelling doaj.art-b186f151d74a431493fce6c042968d1b2022-12-21T22:44:02ZengBMCBMC Cancer1471-24072021-02-0121111210.1186/s12885-021-07840-6Cost-effectiveness of different surgical treatment approaches for early breast cancer: a retrospective matched cohort study from ChinaQing Yang0Xiaorong Zhong1Wei Zhang2Ting Luo3Ping He4Hong Zheng5Institute of Hospital Management, West China Hospital, Sichuan UniversityDepartment of Head, Neck and Mammary Gland Oncology, Cancer Center, West China Hospital, Sichuan UniversityWest China Biomedical Big Data Center, West China Hospital, Sichuan UniversityDepartment of Head, Neck and Mammary Gland Oncology, Cancer Center, West China Hospital, Sichuan UniversityDepartment of Head, Neck and Mammary Gland Oncology, Cancer Center, West China Hospital, Sichuan UniversityDepartment of Head, Neck and Mammary Gland Oncology, Cancer Center, West China Hospital, Sichuan UniversityAbstract Background Both breast-conserving surgery and breast reconstruction surgery are less popular in China, although they can improve patients’ quality of life. The main reason comes from the economy. There is currently no economic evaluation of different surgical treatment options for early breast cancer. Our study aims to assess the economic impact and long-term cost-effectiveness of different surgical treatments for early breast cancer. The surgical approaches are including mastectomy (MAST), breast-conserving therapy (BCT), and mastectomy with reconstruction (MAST+RECON). Methods Based on demographic data, disease-related information and other treatments, we applied propensity score matching (PSM) to perform 1: 1 matching among patients who underwent these three types of surgery in the tertiary academic medical center from 2011 to 2017 to obtain a balanced sample of covariates between groups. A Markov model was established. Clinical data and cost data were obtained from the medical records. Health utility values were derived from clinical investigations. Strategies were compared using an incremental cost-effectiveness ratio (ICER). Results After PSM, there were 205 cases in each group. In the matched data set, the distribution of covariates was fully balanced. The total cost of MAST, MAST+RECON and BCT was $37,392.84, $70,556.03 and $82,330.97, respectively. The quality-adjusted life year (QALYs) were 17.11, 18.40 and 20.20, respectively. Compared with MAST, MAST+RECON and BCT have an ICER of $25,707.90/QALY and $14,543.08/QALY, respectively. The ICER of BCT vs. MAST was less than the threshold of $27,931.04. The reliability and stability of the results were confirmed by Monte Carlo simulation and sensitivity analysis. Conclusions We believe that in the context of the limited resources in China, after comparing the three surgical approaches, BCT is the more cost-effective and preferred solution.https://doi.org/10.1186/s12885-021-07840-6Breast cancerCost-effectivenessMastectomyBreast-conserving therapyBreast reconstruction
spellingShingle Qing Yang
Xiaorong Zhong
Wei Zhang
Ting Luo
Ping He
Hong Zheng
Cost-effectiveness of different surgical treatment approaches for early breast cancer: a retrospective matched cohort study from China
BMC Cancer
Breast cancer
Cost-effectiveness
Mastectomy
Breast-conserving therapy
Breast reconstruction
title Cost-effectiveness of different surgical treatment approaches for early breast cancer: a retrospective matched cohort study from China
title_full Cost-effectiveness of different surgical treatment approaches for early breast cancer: a retrospective matched cohort study from China
title_fullStr Cost-effectiveness of different surgical treatment approaches for early breast cancer: a retrospective matched cohort study from China
title_full_unstemmed Cost-effectiveness of different surgical treatment approaches for early breast cancer: a retrospective matched cohort study from China
title_short Cost-effectiveness of different surgical treatment approaches for early breast cancer: a retrospective matched cohort study from China
title_sort cost effectiveness of different surgical treatment approaches for early breast cancer a retrospective matched cohort study from china
topic Breast cancer
Cost-effectiveness
Mastectomy
Breast-conserving therapy
Breast reconstruction
url https://doi.org/10.1186/s12885-021-07840-6
work_keys_str_mv AT qingyang costeffectivenessofdifferentsurgicaltreatmentapproachesforearlybreastcanceraretrospectivematchedcohortstudyfromchina
AT xiaorongzhong costeffectivenessofdifferentsurgicaltreatmentapproachesforearlybreastcanceraretrospectivematchedcohortstudyfromchina
AT weizhang costeffectivenessofdifferentsurgicaltreatmentapproachesforearlybreastcanceraretrospectivematchedcohortstudyfromchina
AT tingluo costeffectivenessofdifferentsurgicaltreatmentapproachesforearlybreastcanceraretrospectivematchedcohortstudyfromchina
AT pinghe costeffectivenessofdifferentsurgicaltreatmentapproachesforearlybreastcanceraretrospectivematchedcohortstudyfromchina
AT hongzheng costeffectivenessofdifferentsurgicaltreatmentapproachesforearlybreastcanceraretrospectivematchedcohortstudyfromchina